Related Experiment Videos
Matrix metalloproteinases in asthma and COPD.
Ingel K Demedts1, Guy G Brusselle, Ken R Bracke
1Department of Respiratory Diseases, Ghent University Hospital 7K12IE, De Pintelaan 185, B-9000 Ghent, Belgium. M.DemedtsIngelK@UGent.be
Current Opinion in Pharmacology
|May 24, 2005
Summary
Matrix metalloproteinases (MMPs) are key enzymes in lung inflammation and tissue repair. Research suggests MMPs play a role in the development of asthma and chronic obstructive pulmonary disease (COPD), indicating their potential as therapeutic targets.
Area of Science:
- Pulmonology
- Biochemistry
- Pathology
Background:
- Asthma and chronic obstructive pulmonary disease (COPD) are widespread inflammatory lung conditions causing significant illness and death.
- Matrix metalloproteinases (MMPs) are enzymes that degrade the extracellular matrix, crucial for tissue remodeling and regulating inflammatory cell function.
Purpose of the Study:
- To explore the role of matrix metalloproteinases (MMPs) in the pathogenesis of asthma and COPD.
- To identify potential therapeutic targets within MMPs for chronic airway diseases.
Main Methods:
- Review of existing evidence on MMP involvement in respiratory diseases.
- Analysis of MMP functions in inflammation and tissue repair relevant to asthma and COPD.
Main Results:
- Increasing evidence implicates MMPs in the development of asthma and COPD.
- Specific MMPs are identified as potentially critical in disease progression.
Conclusions:
- Matrix metalloproteinases are significantly involved in the pathology of asthma and COPD.
- Targeting specific MMPs presents a promising therapeutic strategy for these prevalent lung diseases.